What Does British American Tobacco (LSE:BATS) Horizon 2030 Mean For Investors?

• British American Tobacco (LSE:BATS) used its 2026 Capital Markets Day to present its Horizon 2030 growth ambitions.
• Management set out long term targets, centred on expanding the New Categories segment within the global nicotine market.
• The Horizon 2030 plan, presented at the 2026 event, outlines how resources will tilt further toward non combustible products.
• The Horizon 2030 New Categories focus is important, but it is only one part of the broader British American Tobacco story. We have also spotted 2 warning signs worth knowing about at British American Tobacco.

For readers interested in more ideas around consumer brands undergoing product shifts, the next place to look is our screener containing 4 high quality undiscovered gems.

British American Tobacco, a £86.0b tobacco group with a broad footprint across the US, Europe and multiple emerging regions, now has to balance this global combustible portfolio with the push into New Categories that management highlighted at the 2026 Capital Markets Day.

4 things going right for British American Tobacco that this headline doesn't cover.

Horizon 2030 puts British American Tobacco’s New Categories thesis to the test

The investment story around British American Tobacco hinges on whether reduced-risk products and digital efficiency can gradually replace a heavily combustible-led profit base. Horizon 2030 speaks directly to that Narrative by spelling out how far and how fast New Categories are expected to scale.

"Digital transformation, operational streamlining, and targeted cost savings programs are releasing capital for reinvestment in high return opportunities and innovation, protecting operating margins and supporting future free cash flow growth…"

See how the full story points towards a £51.50 fair value for British American Tobacco.

Horizon 2030’s push for mid-teens New Categories revenue growth and a 30% plus contribution margin leans into the existing thesis that reduced-risk products can lift profitability over time. That aligns with the focus on Modern Oral, Heated and Vapour in the Narrative and underlines why British American Tobacco is leaning on AI-enabled cost programs to free up cash for these formats.

Guidance for 2026 at the lower end of the 3% to 5% revenue range shows the transition is not frictionless, especially with new UK vape taxes and pressure from rivals like Philip Morris International and Altria. Execution risk around regulation, illicit trade and high New Category investment, already flagged by analysts, looks more immediate when near-term growth is described as tracking toward the floor of the range.

For anyone looking at British American Tobacco, this Capital Markets Day only really matters in the context of whether you accept the underlying Narrative about reduced-risk products and digital efficiency reshaping the business over time.

The final check on British American Tobacco before acting on any of this

Before you act on any story around British American Tobacco, it helps to know who is actually steering the ship and what they are rewarded for delivering. See who is actually steering British American Tobacco, and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com